A round-up of the latest moves in the consumer health market: Reckitt has appointed former Sky chief exec Jeremy Darroch to its board; Genomma Lab is promoting COO Marco Sparvieri to the role of CEO; and Alliance Pharma has announced CEO Peter Butterfield is taking a short period of absence from the company.
Reckitt has appointed Jeremy Darroch, former CEO of broadcaster Sky PLC, to its board of directors with immediate effect.
Darroch will serve as a senior independent non-executive director and as a member of the nomination and remuneration committees.